Hyundai Pharmaceutical Co Ltd
KRX:004310

Watchlist Manager
Hyundai Pharmaceutical Co Ltd Logo
Hyundai Pharmaceutical Co Ltd
KRX:004310
Watchlist
Price: 8 690 KRW 15.56% Market Closed
Market Cap: 227.1B KRW

Intrinsic Value

The intrinsic value of one Hyundai Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 8 690 KRW, Hyundai Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Hyundai Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hyundai Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Hyundai Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Hyundai Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Hyundai Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hyundai Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hyundai Pharmaceutical Co Ltd.

Explain Valuation
Compare Hyundai Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hyundai Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyundai Pharmaceutical Co Ltd

Current Assets 85.1B
Cash & Short-Term Investments 2.3B
Receivables 44.7B
Other Current Assets 38B
Non-Current Assets 78B
Long-Term Investments 27.2B
PP&E 39B
Intangibles 7.1B
Other Non-Current Assets 4.8B
Current Liabilities 73.8B
Accounts Payable 15.8B
Accrued Liabilities 2.1B
Short-Term Debt 43B
Other Current Liabilities 13B
Non-Current Liabilities 9.5B
Long-Term Debt 4.5B
Other Non-Current Liabilities 4.9B
Efficiency

Free Cash Flow Analysis
Hyundai Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hyundai Pharmaceutical Co Ltd

Revenue
185.9B KRW
Cost of Revenue
-109.2B KRW
Gross Profit
76.7B KRW
Operating Expenses
-74.6B KRW
Operating Income
2.1B KRW
Other Expenses
-1.1B KRW
Net Income
1B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hyundai Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
ROE is Increasing
Net Margin is Increasing
hidden
Profitability
Score

Hyundai Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hyundai Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
hidden
Solvency
Score

Hyundai Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hyundai Pharmaceutical Co Ltd

There are no price targets for Hyundai Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hyundai Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hyundai Pharmaceutical Co Ltd stock?

The intrinsic value of one Hyundai Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Hyundai Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 690 KRW, Hyundai Pharmaceutical Co Ltd is hidden .

Back to Top